Endovascular treatment for stroke: When does the window for good outcome close?

The Lancet Neurology

Volumn 13, Issue 6, 2014, Pages 529-531

  Albers, Gregory W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

CEREBROVASCULAR ACCIDENT; ENDOVASCULAR SURGERY; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANKIN SCALE; REPERFUSION; TIME TO TREATMENT; TREATMENT OUTCOME; TREATMENT RESPONSE; ENDOVASCULAR TREATMENT; FOLLOW UP; MEDICAL PROCEDURES; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; SCINTIGRAPHY;

BRAIN ISCHEMIA; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; MALE; REPERFUSION; STROKE;

EID: 84901200639     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70086-9     Document Type: Note

References (9)

1. Khatri P, Yeatts SD, Mazighi M, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 2014, for the IMS III Trialists, published online April 28. http://dx.doi.org/10.1016/S1474-4422(14)70066-3.
2. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013, 368:893-903.
3. Fisher M, Albers GW Advanced imaging to extend the therapeutic time window of acute ischemic stroke. Ann Neurol 2013, 73:4-9.
4. Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012, 11:860-867.
5. Marks MO, Lansberg MG, Mlynash M, et al. Angiographic outcome of endovascular stroke therapy correlated with MR findings, infarct growth, and clinical outcome in the DEFUSE 2 trial. Int J Stroke 2014, for the DEFUSE Investigators, published online March 31. 10.1111/ijs.12271.
6. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013, 368:914-923.
7. Hill MD, Demchuk AM, Goyal M, et al. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke 2014, 45:444-449. for the IMS3 Investigators.
8. Inoue M, Mlynash M, Straka M, et al. Clinical outcomes strongly associated with the degree of reperfusion achieved in target mismatch patients: pooled data from the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution studies. Stroke 2013, 44:1885-1890. for the DEFUSE 1 and 2 Investigators.
9. Leiva-Salinas C, Aghaebrahim A, Zhu G, et al. Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset. Neuroradiology 2013, 55:807-812.